{"id":253,"date":"2023-05-09T11:47:33","date_gmt":"2023-05-09T11:47:33","guid":{"rendered":"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/"},"modified":"2023-05-20T19:15:33","modified_gmt":"2023-05-20T19:15:33","slug":"neuralink-human-trials-2023-what-we-know-so-far","status":"publish","type":"post","link":"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/","title":{"rendered":"Neuralink Human Trials 2023: What We Know So Far"},"content":{"rendered":"<p>\n Elon Musk\u2019s Neuralink has been making headlines for a few years now, sparking curiosity and fascination with its potential to revolutionize the way humans interact with technology. One aspect of Neuralink\u2019s work that has been particularly intriguing is its human trials, which are set to take place in 2023. What are these trials, and what can we expect from them? Let\u2019s dive in and find out.\n<\/p>\n<h2>\n What is Neuralink?<br \/>\n<\/h2>\n<p>\n Before we can talk about the human trials, let\u2019s briefly review Neuralink\u2019s overall mission and technology. Neuralink is a company that aims to merge humans with artificial intelligence by developing brain-machine interfaces. Essentially, they want to create a way for humans to control computers and other devices with their thoughts instead of physical input (e.g. keyboard and mouse). This could have major implications for those who are disabled or have limited mobility, as well as for the general population.\n<\/p>\n<p>\n The technology behind Neuralink involves implanting a small chip into the brain that can communicate with external devices. The chip contains electrodes that can detect and stimulate neurons, allowing for communication between the brain and technology. In theory, this could enable humans to do things like control prosthetic limbs, type with their minds, or even communicate telepathically.\n<\/p>\n<h2>\n Are There Human Trials for Neuralink?<br \/>\n<\/h2>\n<p>\n Yes, there are human trials planned for Neuralink. In fact, the company has already performed some initial human testing, but these were limited to a small number of patients with severe neurological conditions. The upcoming trials in 2023 will be more extensive and will involve a larger number of participants.\n<\/p>\n<h2>\n When Will Neuralink Start Human Trials?<br \/>\n<\/h2>\n<p>\n The exact date of the start of Neuralink\u2019s human trials is unknown at this time. Elon Musk has stated that he hopes they will begin in 2023, but there are many factors that could delay or accelerate the timeline. One major hurdle for Neuralink is obtaining FDA approval for their technology, which could take years. The approval process involves rigorous testing and validation to ensure the safety and efficacy of the implant and its associated software.\n<\/p>\n<h2>\n Is Neuralink Denied FDA Approval?<br \/>\n<\/h2>\n<p>\n It\u2019s too early to say whether or not Neuralink will be denied FDA approval. As previously stated, the approval process is long and complex, and even established companies with successful track records can struggle to obtain clearance. The fact that Neuralink\u2019s technology is so cutting-edge and unique could make the regulatory process even more challenging.\n<\/p>\n<h2>\n What Will Neuralink Allow Humans to Do?<br \/>\n<\/h2>\n<p>Assuming that the human trials are successful and Neuralink eventually obtains FDA approval, what could this mean for humans? The possibilities are nearly endless, but some potential applications include:<\/p>\n<ul>\n<li>Controlling prosthetic limbs with your thoughts<\/li>\n<li>Communicating telepathically with other Neuralink users<\/li>\n<li>Typing with your mind instead of a keyboard<\/li>\n<li>Using your brain to control smart home devices or other technology<\/li>\n<\/ul>\n<h2>\n How Do I Participate in Neuralink Human Trials?<br \/>\n<\/h2>\n<p>If you\u2019re interested in participating in Neuralink\u2019s human trials, you can sign up on their website. However, it\u2019s worth noting that the trials will likely be limited to specific patient populations, such as those with severe neurological conditions or who have already undergone brain surgery. Additionally, the trials will likely involve a significant amount of risk, as any invasive procedure carries the potential for complications.<\/p>\n<h2>\n Neuralink Human Trials Payment<br \/>\n<\/h2>\n<p>It\u2019s not yet clear whether or not participants in the Neuralink human trials will be compensated for their time and participation. Typically, clinical trials of new medical devices or drugs do offer some form of compensation to participants, but this can vary widely depending on the specifics of the trial. Participants may receive payments ranging from a few hundred dollars to several thousand, depending on the length of the trial, the level of risk involved, and other factors.<\/p>\n<h2>\n Neuralink Animal Trials<br \/>\n<\/h2>\n<p>Before Neuralink can move forward with human trials, they must conduct extensive animal testing to ensure the safety and efficacy of their implant. The company has reported success in testing their technology on rats and monkeys, but the leap to humans is much greater in terms of both regulatory oversight and ethical considerations.<\/p>\n<h2>\n Neuralink Brain Chip: What Does it Do?<br \/>\n<\/h2>\n<p>In summary, the Neuralink brain chip is a small implant that is designed to allow humans to control computers and other devices with their thoughts. The chip contains electrodes that can detect and stimulate neurons, allowing for communication between the brain and technology. In theory, this could enable humans to do things like control prosthetic limbs, communicate telepathically, and type with their minds.<\/p>\n<h2>\n How Much Will Neuralink Cost?<br \/>\n<\/h2>\n<p>The cost of Neuralink\u2019s technology is not yet known, but it\u2019s safe to assume that it will be expensive. In addition to the cost of the implant itself, there will likely be ongoing costs associated with maintaining and updating the software and hardware that make the technology work. It\u2019s also worth noting that the cost of any medical procedure can vary widely depending on factors such as location, insurance coverage, and the specific provider.<\/p>\n<h2>\n Neuralink FDA Approval<br \/>\n<\/h2>\n<p>\n Finally, let\u2019s talk about the FDA approval process for Neuralink\u2019s technology. As previously mentioned, this is a major hurdle for the company to overcome, and there\u2019s no guarantee that they will be successful. However, if they do obtain approval, it could be a game-changer for those with neurological conditions or disabilities, as well as for the general population. The benefits of brain-machine interfaces are numerous and could have a significant impact on society as a whole.\n<\/p>\n<p>In conclusion, the upcoming human trials for Neuralink are an exciting development in the field of brain-machine interfaces. While there are still many unknowns and challenges to overcome, the potential benefits of this technology are immense. As the trials progress and more information becomes available, we\u2019ll be watching closely to see what the future holds.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Elon Musk\u2019s Neuralink has been making headlines for a few years now, sparking curiosity and fascination with its potential to revolutionize the way humans interact with technology. One aspect of Neuralink\u2019s work that has been particularly intriguing is its human trials, which are set to take place in 2023. What are these trials, and what &#8230; <a title=\"Neuralink Human Trials 2023: What We Know So Far\" class=\"read-more\" href=\"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/\" aria-label=\"More on Neuralink Human Trials 2023: What We Know So Far\">Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,23,2],"tags":[10,1220,420,1218,409,1215,1213,1217,1222,773,416,1105,423,1223,1221,1219,1216,417,131,1214],"class_list":["post-253","post","type-post","status-publish","format-standard","hentry","category-health","category-lifestyle","category-mental-health","tag-brain","tag-brain-machine-interfaces","tag-company","tag-control-prosthetic-limbs","tag-cost","tag-fda-approval","tag-human-trials","tag-implant","tag-major-implications","tag-minds","tag-neuralink","tag-participants","tag-potential","tag-regulatory-process","tag-severe-neurological-conditions","tag-small-chip","tag-successful-track-records","tag-technology","tag-thoughts","tag-way-humans"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Neuralink Human Trials 2023: What We Know So Far - National Human Neural Stem Cell Resource<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neuralink Human Trials 2023: What We Know So Far - National Human Neural Stem Cell Resource\" \/>\n<meta property=\"og:description\" content=\"Elon Musk\u2019s Neuralink has been making headlines for a few years now, sparking curiosity and fascination with its potential to revolutionize the way humans interact with technology. One aspect of Neuralink\u2019s work that has been particularly intriguing is its human trials, which are set to take place in 2023. What are these trials, and what ... Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/\" \/>\n<meta property=\"og:site_name\" content=\"National Human Neural Stem Cell Resource\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-09T11:47:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-20T19:15:33+00:00\" \/>\n<meta name=\"author\" content=\"nhnscr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"nhnscr\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/\"},\"author\":{\"name\":\"nhnscr\",\"@id\":\"https:\/\/www.nhnscr.org\/blog\/#\/schema\/person\/d41d29640995f187f244eee982914121\"},\"headline\":\"Neuralink Human Trials 2023: What We Know So Far\",\"datePublished\":\"2023-05-09T11:47:33+00:00\",\"dateModified\":\"2023-05-20T19:15:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/\"},\"wordCount\":989,\"publisher\":{\"@id\":\"https:\/\/www.nhnscr.org\/blog\/#organization\"},\"keywords\":[\"brain\",\"brain-machine interfaces\",\"company\",\"control prosthetic limbs\",\"cost\",\"fda approval\",\"human trials\",\"implant\",\"major implications\",\"minds\",\"neuralink\",\"participants\",\"potential\",\"regulatory process\",\"severe neurological conditions\",\"small chip\",\"successful track records\",\"technology\",\"thoughts\",\"way humans\"],\"articleSection\":[\"Health\",\"Lifestyle\",\"Mental Health\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/\",\"url\":\"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/\",\"name\":\"Neuralink Human Trials 2023: What We Know So Far - National Human Neural Stem Cell Resource\",\"isPartOf\":{\"@id\":\"https:\/\/www.nhnscr.org\/blog\/#website\"},\"datePublished\":\"2023-05-09T11:47:33+00:00\",\"dateModified\":\"2023-05-20T19:15:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.nhnscr.org\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neuralink Human Trials 2023: What We Know So Far\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.nhnscr.org\/blog\/#website\",\"url\":\"https:\/\/www.nhnscr.org\/blog\/\",\"name\":\"National Human Neural Stem Cell Resource\",\"description\":\"Blog\",\"publisher\":{\"@id\":\"https:\/\/www.nhnscr.org\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.nhnscr.org\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.nhnscr.org\/blog\/#organization\",\"name\":\"National Human Neural Stem Cell Resource\",\"url\":\"https:\/\/www.nhnscr.org\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.nhnscr.org\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.nhnscr.org\/blog\/wp-content\/uploads\/2023\/04\/cropped-logo.png\",\"contentUrl\":\"https:\/\/www.nhnscr.org\/blog\/wp-content\/uploads\/2023\/04\/cropped-logo.png\",\"width\":500,\"height\":100,\"caption\":\"National Human Neural Stem Cell Resource\"},\"image\":{\"@id\":\"https:\/\/www.nhnscr.org\/blog\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.nhnscr.org\/blog\/#\/schema\/person\/d41d29640995f187f244eee982914121\",\"name\":\"nhnscr\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.nhnscr.org\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/82dea9b11335369a4f9d0a60664e5aa1c81e38991ce030ace6f5377586f4668d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/82dea9b11335369a4f9d0a60664e5aa1c81e38991ce030ace6f5377586f4668d?s=96&d=mm&r=g\",\"caption\":\"nhnscr\"},\"sameAs\":[\"https:\/\/www.nhnscr.org\/blog\"],\"url\":\"https:\/\/www.nhnscr.org\/blog\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neuralink Human Trials 2023: What We Know So Far - National Human Neural Stem Cell Resource","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/","og_locale":"en_US","og_type":"article","og_title":"Neuralink Human Trials 2023: What We Know So Far - National Human Neural Stem Cell Resource","og_description":"Elon Musk\u2019s Neuralink has been making headlines for a few years now, sparking curiosity and fascination with its potential to revolutionize the way humans interact with technology. One aspect of Neuralink\u2019s work that has been particularly intriguing is its human trials, which are set to take place in 2023. What are these trials, and what ... Read more","og_url":"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/","og_site_name":"National Human Neural Stem Cell Resource","article_published_time":"2023-05-09T11:47:33+00:00","article_modified_time":"2023-05-20T19:15:33+00:00","author":"nhnscr","twitter_card":"summary_large_image","twitter_misc":{"Written by":"nhnscr","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/#article","isPartOf":{"@id":"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/"},"author":{"name":"nhnscr","@id":"https:\/\/www.nhnscr.org\/blog\/#\/schema\/person\/d41d29640995f187f244eee982914121"},"headline":"Neuralink Human Trials 2023: What We Know So Far","datePublished":"2023-05-09T11:47:33+00:00","dateModified":"2023-05-20T19:15:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/"},"wordCount":989,"publisher":{"@id":"https:\/\/www.nhnscr.org\/blog\/#organization"},"keywords":["brain","brain-machine interfaces","company","control prosthetic limbs","cost","fda approval","human trials","implant","major implications","minds","neuralink","participants","potential","regulatory process","severe neurological conditions","small chip","successful track records","technology","thoughts","way humans"],"articleSection":["Health","Lifestyle","Mental Health"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/","url":"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/","name":"Neuralink Human Trials 2023: What We Know So Far - National Human Neural Stem Cell Resource","isPartOf":{"@id":"https:\/\/www.nhnscr.org\/blog\/#website"},"datePublished":"2023-05-09T11:47:33+00:00","dateModified":"2023-05-20T19:15:33+00:00","breadcrumb":{"@id":"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.nhnscr.org\/blog\/neuralink-human-trials-2023-what-we-know-so-far\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.nhnscr.org\/blog\/"},{"@type":"ListItem","position":2,"name":"Neuralink Human Trials 2023: What We Know So Far"}]},{"@type":"WebSite","@id":"https:\/\/www.nhnscr.org\/blog\/#website","url":"https:\/\/www.nhnscr.org\/blog\/","name":"National Human Neural Stem Cell Resource","description":"Blog","publisher":{"@id":"https:\/\/www.nhnscr.org\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.nhnscr.org\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.nhnscr.org\/blog\/#organization","name":"National Human Neural Stem Cell Resource","url":"https:\/\/www.nhnscr.org\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.nhnscr.org\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.nhnscr.org\/blog\/wp-content\/uploads\/2023\/04\/cropped-logo.png","contentUrl":"https:\/\/www.nhnscr.org\/blog\/wp-content\/uploads\/2023\/04\/cropped-logo.png","width":500,"height":100,"caption":"National Human Neural Stem Cell Resource"},"image":{"@id":"https:\/\/www.nhnscr.org\/blog\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.nhnscr.org\/blog\/#\/schema\/person\/d41d29640995f187f244eee982914121","name":"nhnscr","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.nhnscr.org\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/82dea9b11335369a4f9d0a60664e5aa1c81e38991ce030ace6f5377586f4668d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/82dea9b11335369a4f9d0a60664e5aa1c81e38991ce030ace6f5377586f4668d?s=96&d=mm&r=g","caption":"nhnscr"},"sameAs":["https:\/\/www.nhnscr.org\/blog"],"url":"https:\/\/www.nhnscr.org\/blog\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.nhnscr.org\/blog\/wp-json\/wp\/v2\/posts\/253","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nhnscr.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nhnscr.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nhnscr.org\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nhnscr.org\/blog\/wp-json\/wp\/v2\/comments?post=253"}],"version-history":[{"count":2,"href":"https:\/\/www.nhnscr.org\/blog\/wp-json\/wp\/v2\/posts\/253\/revisions"}],"predecessor-version":[{"id":784,"href":"https:\/\/www.nhnscr.org\/blog\/wp-json\/wp\/v2\/posts\/253\/revisions\/784"}],"wp:attachment":[{"href":"https:\/\/www.nhnscr.org\/blog\/wp-json\/wp\/v2\/media?parent=253"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nhnscr.org\/blog\/wp-json\/wp\/v2\/categories?post=253"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nhnscr.org\/blog\/wp-json\/wp\/v2\/tags?post=253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}